Outlook Therapeutics
OTLK
OTLK
82 hedge funds and large institutions have $29.7M invested in Outlook Therapeutics in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+7
Holders Change %
+9.33%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
34
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$8.79M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$2.77M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$6.55M |
| 4 |
4
Millennium Management
New York
|
$562K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.31M |
